Bristol-Myers Squibb Company
Bristol-Myers Squibb Homepage Information About Bristol-Myers Squibb Bristol-Myers Squibb Newsroom Pharmaceuticals and Over-the-Counter Medicines Pharmaceutical R&D Information for Institutional and Individual Investors Alliances Corporate Responsibility Careers with Bristol-Myers Squibb
Medicines
Beauty Care
Nutritionals
Medical Devices
Insurance Verification
Supplier Information
Supplier Diversity
U.S.
International


Read more >>

SEARCH INDEX
 
 

UNRESTRICTED BIOMEDICAL RESEARCH GRANTS PROGRAM

We cannot be a strong nation unless we are healthy nation. And so we must recruit not only men and women and materials but also knowledge and science in the service of national strength.

Christopher Reeve    

A little over half a century ago, in the midst of rapidly escalating world war, President Franklin Delano Roosevelt made this connection between our country’s strength and its health in dedicating the National Institutes of Health. Since that time, more afflictions and diseases have been cured, eradicated or successfully treated than in all the previous years of human history.

Today, we stand on the verge of mastering still more illnesses. In this age of wide-ranging discovery, the Bristol-Myers Squibb Foundation’s unrestricted research grants to scientists represent a singular contribution to human hope and destiny. The $500,000 grants are awarded to scientists pursuing promising avenues of original research. Remarkably, these grants are made with no strings attached, allowing dedicated scientists to follow their instincts and their research wherever they may lead.

Indeed, two recipients of the Foundation’s unrestricted grants -- Dr. Dennis Choi of Washington University School of Medicine, and Dr. Fred Gage of the Salk Institute for Biological Studies -- were recently awarded the Christopher Reeve Research Medal by the Reeve-Irvine Research Center at the University of California-Irvine College of Medicine for their breakthrough research on spinal cord injuries. Their progress, along with that of dozens of other recipients of unrestricted grants from the Bristol-Myers Squibb Foundation, are proof that the freedom to follow one’s scientific instincts can be a significant step in freeing us all from the debilitating effects of injury and disease.

-- Christopher Reeve
Actor and Director




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

 
SEARCH INDEX